Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 139


Rituximab Maintenance for a Maximum of 5 Years After Single-Agent Rituximab Induction in Follicular Lymphoma: Results of the Randomized Controlled Phase III Trial SAKK 35/03.

Taverna C, Martinelli G, Hitz F, Mingrone W, Pabst T, Cevreska L, Del Giglio A, Vanazzi A, Laszlo D, Raats J, Rauch D, Vorobiof DA, Lohri A, Biaggi Rudolf C, Rondeau S, Rusterholz C, Heijnen IA, Zucca E, Ghielmini M.

J Clin Oncol. 2016 Feb 10;34(5):495-500. doi: 10.1200/JCO.2015.61.3968. Epub 2015 Dec 28.


Clinical features and overall survival among elderly cancer patients in a tertiary cancer center.

Antunes YP, Bugano DD, Del Giglio A, Kaliks RA, Karnakis T, Pontes Lde B.

Einstein (Sao Paulo). 2015 Dec;13(4):487-91. doi: 10.1590/S1679-45082015AO3067. Epub 2015 Dec 11. English, Portuguese.


Adjuvant treatment delay in breast cancer patients.

Trufelli DC, Matos LL, Santi PX, Del Giglio A.

Rev Assoc Med Bras. 2015 Sep-Oct;61(5):411-6. doi: 10.1590/1806-9282.61.05.411.


Applicability of modified Glasgow Prognostic Score in the assessment of elderly patients with cancer: A pilot study.

Lealdini V, Trufelli DC, da Silva FB, Normando SR, Camargo EW, Matos LL, Fonseca FL, Santi PX, Del Giglio A.

J Geriatr Oncol. 2015 Nov;6(6):479-83. doi: 10.1016/j.jgo.2015.09.001. Epub 2015 Oct 4.


Fatigue in Patients With Advanced Terminal Cancer Correlates With Inflammation, Poor Quality of Life and Sleep, and Anxiety/Depression.

Rodrigues AR, Trufelli DC, Fonseca F, de LC, Del Giglio A.

Am J Hosp Palliat Care. 2015 Aug 30. pii: 1049909115603055. [Epub ahead of print]


Complete pathologic response as a prognostic factor for squamous cell carcinoma of the oropharynx post-chemoradiotherapy.

Trufelli DC, Matos LL, Santana TA, Capelli Fde A, Kanda JL, Del Giglio A, Castro Junior Gd.

Braz J Otorhinolaryngol. 2015 Sep-Oct;81(5):498-504. doi: 10.1016/j.bjorl.2015.07.009. Epub 2015 Jul 21.


Cumulative meta-analysis of epidermal growth factor receptor-tyrosine kinase inhibitors as first-line therapy in metastatic non-small-cell lung cancer.

Normando SR, Cruz FM, Del Giglio A.

Anticancer Drugs. 2015 Oct;26(9):995-1003. doi: 10.1097/CAD.0000000000000268.


Erratum to: The biology of cancer-related fatigue: a review of the literature.

Saligan LN, Olson K, Filler K, Larkin D, Cramp F, Yennurajalingam S, Escalante CP, del Giglio A, Kober KM, Kamath J, Palesh O, Mustian K; Multinational Association of Supportive Care in Cancer Fatigue StudyGroup–Biomarker Working Group.

Support Care Cancer. 2015 Sep;23(9):2853. doi: 10.1007/s00520-015-2815-5. No abstract available.


Gene profiling and circulating tumor cells as biomarker to prognostic of patients with locoregional breast cancer.

Kuniyoshi RK, Gehrke Fde S, Alves BC, Vilas-Bôas V, Coló AE, Sousa N, Nunes J, Fonseca FL, Del Giglio A.

Tumour Biol. 2015 Sep;36(10):8075-83. doi: 10.1007/s13277-015-3529-5. Epub 2015 May 16.


The biology of cancer-related fatigue: a review of the literature.

Saligan LN, Olson K, Filler K, Larkin D, Cramp F, Yennurajalingam S, Escalante CP, del Giglio A, Kober KM, Kamath J, Palesh O, Mustian K; Multinational Association of Supportive Care in Cancer Fatigue Study Group-Biomarker Working Group.

Support Care Cancer. 2015 Aug;23(8):2461-78. doi: 10.1007/s00520-015-2763-0. Epub 2015 May 15. Review. Erratum in: Support Care Cancer. 2015 Sep;23(9):2853. Sriram, Yennu [corrected to Yennurajalingam, Sriram].


"Burnout in Medical Oncology Fellows: a Prospective Multicenter Cohort Study in Brazilian Institutions".

Cubero DI, Fumis RR, de Sá TH, Dettino A, Costa FO, Van Eyll BM, Beato C, Peria FM, Mota A, Altino J, Azevedo SJ, da Rocha Filho DR, Moura M, Lessa ÁE, Del Giglio A.

J Cancer Educ. 2015 May 9. [Epub ahead of print]


Biomarkers of fatigue related to adjuvant chemotherapy for breast cancer: evaluation of plasma and lymphocyte expression.

Cruz FM, Munhoz BA, Alves BC, Gehrke FS, Fonseca FL, Kuniyoshi RK, Cubero D, Peppone LJ, Del Giglio A.

Clin Transl Med. 2015 Feb 14;4:4. doi: 10.1186/s40169-015-0051-8. eCollection 2015.


Guarana (Paullinia cupana) Improves Anorexia in Patients with Advanced Cancer.

Palma CG, Lera AT, Lerner T, de Oliveira MM, de Borta TM, Barbosa RP, Brito GM, Guazzelli CA, Cruz FJ, del Giglio A.

J Diet Suppl. 2016;13(2):221-31. doi: 10.3109/19390211.2015.1008612. Epub 2015 Feb 19.


From one side to the other: what is essential? Perception of oncology patients and their caregivers in the beginning of oncology treatment and in palliative care.

Munhoz BA, Paiva HS, Abdalla BM, Zaremba G, Rodrigues AM, Carretti MR, Monteiro CR, Zara A, Silva JO, Assis WB, Auresco LC, Pereira LL, Giglio AB, Lepori AC, Trufelli DC, del Giglio A.

Einstein (Sao Paulo). 2014 Oct-Dec;12(4):485-91. doi: 10.1590/S1679-45082014RC3091. Epub 2014 Dec 16. English, Portuguese.


Uncaria tomentosa (cat's claw) improves quality of life in patients with advanced solid tumors.

de Paula LC, Fonseca F, Perazzo F, Cruz FM, Cubero D, Trufelli DC, Martins SP, Santi PX, da Silva EA, Del Giglio A.

J Altern Complement Med. 2015 Jan;21(1):22-30. doi: 10.1089/acm.2014.0127. Epub 2014 Dec 11.


Azacitidine and lenalidomide as an alternative treatment for refractory acute myeloid leukemia: a case report.

Todaro J, Bollmann PW, Rother ET, del Giglio A.

Sao Paulo Med J. 2015 May-Jun;133(3):271-4. doi: 10.1590/1516-3180.2012.6790006. Epub 2014 Sep 19.


Meta-analysis of adjunctive non-NK1 receptor antagonist medications for the control of acute and delayed chemotherapy-induced nausea and vomiting.

Santana TA, Trufelli DC, Matos LL, Cruz FM, Del Giglio A.

Support Care Cancer. 2015 Jan;23(1):213-22. doi: 10.1007/s00520-014-2392-z. Epub 2014 Aug 22.


Serum crosslinked-N-terminal telopeptide of type I collagen (NTx) has prognostic implications for patients with initial prostate carcinoma (PCa): a pilot study.

Jablonka F, Alves Bda C, de Oliveira CG, Wroclawski ML, Szwarc M, Vitória Wde O, Fonseca F, Del Giglio A.

Clin Chim Acta. 2014 Sep 25;436:316-8. doi: 10.1016/j.cca.2014.06.025. Epub 2014 Jun 30.


Carbamazepine for prevention of chemotherapy-induced nausea and vomiting: a pilot study.

Santana TA, Cruz FM, Trufelli DC, Glasberg J, Del Giglio A.

Sao Paulo Med J. 2014;132(3):147-51. Epub 2014 Apr 14.


Randomized phase III trial exploring the use of long-acting release octreotide in the prevention of chemotherapy-induced diarrhea in patients with colorectal cancer: the LARCID trial.

Hoff PM, Saragiotto DF, Barrios CH, del Giglio A, Coutinho AK, Andrade AC, Dutra C, Forones NM, Correa M, Portella Mdo S, Passos VQ, Chinen RN, van Eyll B.

J Clin Oncol. 2014 Apr 1;32(10):1006-11. doi: 10.1200/JCO.2013.50.8077. Epub 2014 Feb 10.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk